Yi-Chen Lai
National Sun Yat-sen University1 paperOpenAlex
Papers
Drug Design, Development and TherapyHumans
GLP-1 agonists linked to lower dementia risk after COVID-19
GLP-1 receptor agonist initiation was associated with a lower hazard of incident dementia than DPP-4 inhibitors (HR 0.64) in diabetic COVID-19…GLP-1 receptor agonist initiation was associated with a lower hazard of incident dementia than DPP-4 inhibitors (HR 0.64) in diabetic COVID-19 survivors.